2007
DOI: 10.1016/j.jbi.2006.02.012
|View full text |Cite
|
Sign up to set email alerts
|

Status of clinical gene sequencing data reporting and associated risks for information loss

Abstract: Clinical gene sequencing is growing in importance and cost-effectiveness. In the past two years, the number of genes associated with disease has grown by roughly 25%. Knowledge of genetic variations will soon guide drug selection and dosages, predict risks from toxin exposures, and inform nutritional needs. Despite the significance of sequencing, methods for reporting results are problematic. Frequent use of paper and infrequent use of naming standards impede data exchange and make incorporation into the elect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2007
2007
2013
2013

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 22 publications
0
15
0
Order By: Relevance
“…A common limitation is not only a lack of structured data that could be used for clinical decision support but also the focus on reporting of variants as opposed to all observations made. 24 …”
Section: Use and Limitations In The Clinical Settingmentioning
confidence: 99%
“…A common limitation is not only a lack of structured data that could be used for clinical decision support but also the focus on reporting of variants as opposed to all observations made. 24 …”
Section: Use and Limitations In The Clinical Settingmentioning
confidence: 99%
“…Discrete genetic data are important as a foundation for decision support, as a means of exchanging data between clinical organizations, whether reference labs and ordering physicians, or ultimately in the context of continuity of care across patient venues. Extension of these systems to manage DNA sequence results, both single gene and whole genome sequencing (WGS), is a likely progression of these efforts (Mitchell and Mitchell 2007).…”
Section: Discretely Stored Genetic Test Resultsmentioning
confidence: 99%
“…Additionally, genetic test development is not yet regulated by the Clinical Laboratory Improvement Amendments (CLIA) oversight process. There is tremendous variability in the degree of information and interpretation of results returned by different laboratories, making it challenging for a non-genetics specialist to interpret genetic test results accurately [24,25]. These issues can create significant ambiguity about result interpretation, and decisions regarding medical record access to these results should consider the clinical utility of the findings and the availability of clinical decision support systems to guide healthcare provider use of test findings.…”
Section: Discussionmentioning
confidence: 99%